HIV, HCV, and gender effects on Liver, Bone, and Vascular Health

Investigator: Phyllis Tien, MD
Sponsor: NIH National Institute of Allergy and Infectious Disease

Location(s): United States


 As the proportion of U.S. HIV-infected men and women over the age of 50 years increases to over 50% by the year 2015, it will be of critical importance to understand the influence of HIV infection, HCV infection, the menopausal transition and their associated immune and metabolic perturbations to changes in the trajectory of liver, bone, and vascular injury. Dr. Tien proposes to expand her research program to investigate long term organ injury by building collaborations with mentees across a range of disciplines (e.g. hepatology, endocrinology, and cardiology) and seeking additional training in mentoring and professional leadership development. Together they will enrich her research program and develop the next generation of clinical investigators in high priority HIV and HCV research.